Physician profile
Paige A Nabors
NPI 1396200408
$2,881.92
in general payments reported to CMS, 2019-2025
18 companies · $462 in 2025
The $462 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $170 · 2022: $214 · 2023: $150 · 2024: $1,885 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,523 · Travel and Lodging: $974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,523.15 |
| Travel and Lodging | $974.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,647.41 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Urovant Sciences INC | $368.27 | 2021-2022 | |
| Lemaitre Vascular, INC. | $160.73 | 2024-2025 | Artegraft Vascular Graft, Pruitt F3 Carotid Shunt, Xenosure Biologic Patch |
| Sumitomo Pharma America, INC. | $122.66 | 2023-2024 | Gemtesa |
| Abiomed | $112.00 | 2024-2025 | Impella |
| Abbott Laboratories | $69.97 | 2025 | Navitor, Mitraclip |
| W. L. Gore & Associates, INC. | $65.03 | 2023-2024 | Gore Excluder Aaa Endoprosthesis, Gore Excluder Iliac Branch Endoprosthesis, Gore Tag Conformable Thoracic Stent Graft |
| Medtronic, INC. | $55.43 | 2025 | Corevalve Evolut R |
| Dilon Technologies, INC. | $44.90 | 2025 | Hemoblast Bellows |
| Kerecis Limited | $39.95 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Artivion, INC. | $37.76 | 2025 | Amds-Ascyrus Medical, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Boston Scientific Corporation | $37.50 | 2025 | Enroute Transcarotid Stent |
| Merck Sharp & Dohme LLC | $26.52 | 2025 | Keytruda |
| Stimlabs LLC | $22.94 | 2025 | Corplex P |
| Bridgebio Pharma, INC. | $20.99 | 2025 | Attruby |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $18.82 | 2024 | Activ.A.C. |
| Atricure, INC. | $16.35 | 2021 | |
| Stryker Corporation | $14.69 | 2024 | Sonopet Iq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paige Nabors listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.